Background We aimed to systematically review the health preference literature using
discrete choice experiments (DCEs), an attribute-based stated preference method, to …

Daily oral pre-exposure prophylaxis (PrEP) is the use of antiretroviral drugs by HIV-negative
people to prevent HIV infection. WHO released new guidelines in 2015 recommending PrEP …

Pre-exposure prophylaxis (PrEP) is a highly effective HIV prevention tool. Long-acting
injectable PrEP (LAI-PrEP) offers another opportunity to reduce HIV. However, how at-risk …

Future cost effectiveness studies should consider PrEP implementation issues (uptake in
high-risk versus low-risk groups, duration on PrEP, adherence), budget impact, and the role …

Background Men who have sex with men (MSM) and transgender women (TGW) are
disproportionally affected by HIV infection in Latin America. This study aims to assess pre …

Background: Delivery and use of HIV pre-exposure prophylaxis (PrEP) are suboptimal in the
United States. Previous reviews of barriers and facilitators have not used an implementation …

Introduction: Despite documented effectiveness of pre-exposure prophylaxis (PrEP), PrEP
uptake remains low among men who have sex with men (MSM), the population bearing the …

Background The use of antiviral medications by HIV negative people to prevent acquisition
of HIV or pre-exposure prophylaxis (PrEP) has shown promising results in recent trials. To …

Although people who use drugs (PWUD) are one of the key risk populations who could
benefit from the use of pre-exposure prophylaxis (PrEP), to date, little attention has been …

Abstract Purpose of Review Standard care for HIV pre-exposure prophylaxis (PrEP) in the
USA creates substantial burdens for patients, clinicians, and the healthcare system; to …